Alia Al Tikriti
Overview
Explore the profile of Alia Al Tikriti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daggag H, Gjesing A, Mohammad A, Angquist L, Shobi B, Antony S, et al.
Metabol Open
. 2022 Nov;
16:100213.
PMID: 36407475
Aims: To investigate the prevalence of pathogenic variants in monogenic diabetes genes in Emirati women with gestational diabetes (GDM) and examine the risk of developing hyperglycemia during follow-up in carriers...
2.
Iqbal S, Sabbour H, Siddiqui M, Al Tikriti A, Santos R, Buckley A
Clin Ther
. 2022 Sep;
44(10):1297-1309.
PMID: 36127165
Purpose: Evolocumab, a monoclonal inhibitor of proprotein convertase subtilisin/kexin 9, has been shown to reduce proatherogenic lipoproteins in patients with or without familial hypercholesterolemia (FH), diabetes mellitus, or atherosclerotic cardiovascular...
3.
Elliott K, Haber M, Daggag H, Busby G, Sarwar R, Kennet D, et al.
Mol Biol Evol
. 2022 Feb;
39(3).
PMID: 35192718
The indigenous population of the United Arab Emirates (UAE) has a unique demographic and cultural history. Its tradition of endogamy and consanguinity is expected to produce genetic homogeneity and partitioning...
4.
Rimbert A, Daggag H, Lansberg P, Buckley A, Viel M, Kanninga R, et al.
Front Genet
. 2022 Jan;
12:809256.
PMID: 35047021
Programs to screen for Familial hypercholesterolemia (FH) are conducted worldwide. In Western societies, these programs have been shown to be cost-effective with hit/detection rates of 1 in 217-250. Thus far,...
5.
Suliman M, Buckley A, Al Tikriti A, Tan T, le Roux C, Lessan N, et al.
Diabetes Obes Metab
. 2019 Feb;
21(6):1498-1501.
PMID: 30768836
In this study we prospectively collected data on the use of liraglutide 3 mg in obese Arab patients. As part of routine care, 2092 patients were dispensed liraglutide 3 mg....
6.
Maddaloni E, Lessan N, Al Tikriti A, Buzzetti R, Pozzilli P, Barakat M
PLoS One
. 2015 Aug;
10(8):e0131837.
PMID: 26252955
Aims: To describe and to characterize clinical features of latent autoimmune diabetes in adults (LADA) compared to type 1 and type 2 diabetes in the UAE. Methods: In this cross-sectional...